Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer.

David D'Andrea; Peter C. Black; Homayoun Zargar; Colin P.N. Dinney; Francesco Soria; Michael S. Cookson; Jeffrey S. Montgomery; Wassim Kassouf; Marc A. Dall'Era; Srikala S. Sridhar; Philippe E. Spiess; Shahrokh F. Shariat

doi:https://doi.org/10.1097/ju.0000000000002190

doi.org/10.1097/ju.0000000000002190

Other

Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer.

,

,

..., Shahrokh F. Shariat

116

The Journal of Urology5.90

Published: Aug 27, 2021

Abstract

Purpose:We investigated the pathological response rates and survival associated with 3 vs 4 cycles of cisplatin-based neoadjuvant chemotherapy (NAC) in patients with cT2-4N0M0 muscle invasive...

Paper Fields

Paper Details

Title

Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer.

DOI

doi.org/10.1097/ju.0000000000002190

Published Date

Aug 27, 2021

Journal

The Journal of Urology

Citation AnalysisPro

You’ll need to upgrade your plan to Pro

Looking to understand the true influence of a researcher’s work across journals & affiliations?

Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.

More information

Notes

History